Breast Cancer Research and Treatment

Glucocorticoid receptor and breast cancer
pp. 1-10(10)
Authors: Vilasco, Myriam; Communal, Laudine; Mourra, Najat; Courtin, Aurélie; Forgez, Patricia; Gompel, Anne

Real-time elastography for the differentiation of benign and malignant breast lesions: a meta-analysis
pp. 11-18(8)
Authors: Gong, Xia; Xu, Qiuhua; Xu, Zhengliang; Xiong, Ping; Yan, Weili; Chen, Yazhu

CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways
pp. 19-27(9)
Authors: Lim, Ji-Hong; Kim, Tae-You; Kim, Woo-Ho; Park, Jong-Wan

HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib
pp. 29-40(12)
Authors: Valabrega, Giorgio; Capellero, Sonia; Cavalloni, Giuliana; Zaccarello, Gianluca; Petrelli, Annalisa; Migliardi, Giorgia; Milani, Andrea; Peraldo-Neia, Caterina; Gammaitoni, Loretta; Sapino, Anna; Pecchioni, Carla; Moggio, Aldo; Giordano, Silvia; Aglietta, Massimo; Montemurro, Filippo

A long AAAG repeat allele in the 5′ UTR of the ERR-γ gene is correlated with breast cancer predisposition and drives promoter activity in MCF-7 breast cancer cells
pp. 41-48(8)
Authors: Galindo, C.; McCormick, J.; Bubb, V.; Abid Alkadem, D.; Li, Long-Shan; McIver, L.; George, A.; Boothman, D.; Quinn, J.; Skinner, M.; Garner, H.

Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice
pp. 49-60(12)
Authors: Gorczynski, Reginald; Clark, David; Erin, Nuray; Khatri, Ismat

Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice
pp. 61-71(11)
Authors: Kim, Eun; Hong, Ji; Eom, Soon; Lee, Jae-Yong; Park, Jung

Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells
pp. 73-83(11)
Authors: Phuong, Nguyen; Kim, Sang; Lim, Sung; Kim, Hyung; Kim, Tae; Lee, Kwang; Ahn, Sang-Gun; Yoon, Jung-Hoon; Kang, Keon

PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo
pp. 85-96(12)
Authors: Ma, Jin-gui; Huang, He; Chen, Si-meng; Chen, Yi; Xin, Xian-liang; Lin, Li-ping; Ding, Jian; Liu, Hong; Meng, Ling-hua

Post-lumpectomy intracavitary retention and lymph node targeting of ^99mTc-encapsulated liposomes in nude rats with breast cancer xenograft
pp. 97-107(11)
Authors: Li, Shihong; Goins, Beth; Phillips, William; Saenz, Marcela; Otto, Pamela; Bao, Ande

Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients
pp. 109-117(9)
Authors: Göbel, Georg; Auer, Doris; Gaugg, Inge; Schneitter, Alois; Lesche, Ralf; Müller-Holzner, Elisabeth; Marth, Christian; Daxenbichler, Günter

Circulating free DNA: a new surrogate marker for minimal residual disease?
pp. 119-122(4)
Authors: Fehm, Tanja; Banys, Malgorzata

SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer
pp. 123-131(9)
Authors: Livingston, Robert; Barlow, William; Kash, Joseph; Albain, Kathy; Gralow, Julie; Lew, Danika; Flaherty, Lawrence; Royce, Melanie; Hortobagyi, Gabriel

Final overall survival results and effect of prolonged (≥1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial
pp. 133-143(11)
Authors: Smith, Ian; Pierga, Jean-Yves; Biganzoli, Laura; Cortes-Funes, Hernan; Thomssen, Christoph; Saracchini, Silvana; Nisenbaum, Bella; Pelaez, Ignacio; Duenne, Anja-Alexandra; Pritchard, Kathleen

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations
pp. 145-153(9)
Authors: Bayraktar, Soley; Gutierrez-Barrera, Angelica; Liu, Diane; Tasbas, Tunc; Akar, Ugur; Litton, Jennifer; Lin, E.; Albarracin, Constance; Meric-Bernstam, Funda; Gonzalez-Angulo, Ana; Hortobagyi, Gabriel; Arun, Banu

First generation prognostic gene signatures for breast cancer predict both survival and chemotherapy sensitivity and identify overlapping patient populations
pp. 155-164(10)
Authors: Iwamoto, Takayuki; Lee, Ju-Seog; Bianchini, Giampaolo; Hubbard, Rebekah; Young, Elliana; Matsuoka, Junji; Kim, Sang; Symmans, W.; Hortobagyi, Gabriel; Pusztai, Lajos

Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer
pp. 165-173(9)
Authors: Liu, Ying; Pérez, Maria; Schootman, Mario; Aft, Rebecca; Gillanders, William; Jeffe, Donna

The association of reproductive factors and breastfeeding with long term survival from breast cancer
pp. 175-182(8)
Authors: Alsaker, Mirjam; Opdahl, Signe; Åsvold, Bjørn; Romundstad, Pål; Vatten, Lars

Associations of objectively assessed physical activity and sedentary time with biomarkers of breast cancer risk in postmenopausal women: findings from NHANES (2003-2006)
pp. 183-194(12)
Authors: Lynch, Brigid; Friedenreich, Christine; Winkler, Elisabeth; Healy, Geneviève; Vallance, Jeff; Eakin, Elizabeth; Owen, Neville

Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study
pp. 195-205(11)
Authors: Kwan, Marilyn; Greenlee, Heather; Lee, Valerie; Castillo, Adrienne; Gunderson, Erica; Habel, Laurel; Kushi, Lawrence; Sweeney, Carol; Tam, Emily; Caan, Bette

Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations
pp. 207-215(9)
Authors: Manoukian, Siranoush; Peissel, Bernard; Frigerio, Simona; Lecis, Daniele; Bartkova, Jirina; Roversi, Gaia; Radice, Paolo; Bartek, Jiri; Delia, Domenico

Genotypes and phenotypes of IGF-I and IGFBP-3 in breast tumors among Chinese women
pp. 217-226(10)
Authors: Qian, Biyun; Zheng, Hong; Yu, Herbert; Chen, Kexin

Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial
pp. 227-234(8)
Authors: Hayes, Sandra; Speck, Rebecca; Reimet, Elizabeth; Stark, Azadeh; Schmitz, Kathryn

Absenteeism and short-term disability associated with breast cancer
pp. 235-242(8)
Authors: Fu, Alex; Chen, Lei; Sullivan, Sean; Christiansen, Neal

Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life
pp. 243-254(12)
Authors: Alfano, Catherine; Lichstein, Kenneth; Vander Wal, Gregory; Smith, Ashley; Reeve, Bryce; McTiernan, Anne; Bernstein, Leslie; Baumgartner, Kathy; Ballard-Barbash, Rachel

Effect of primary prophylactic G-CSF use on systemic therapy administration for elderly breast cancer patients
pp. 255-266(12)
Authors: Rajan, Suja; Stearns, Sally; Lyman, Gary; Carpenter, William

Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients
pp. 267-272(6)
Authors: Ohsumi, Shozo; Inoue, Takeshi; Kiyoto, Sachiko; Hara, Fumikata; Takahashi, Mina; Takabatake, Daisuke; Takashima, Seiki; Aogi, Kenjiro; Takashima, Shigemitsu

Mothers' pre-pregnancy BMI and weight gain during pregnancy and risk of breast cancer in daughters
pp. 273-279(7)
Authors: Wilson, Kathryn; Willett, Walter; Michels, Karin

Pathological characteristics of BRCA-associated breast cancers in Hispanics
pp. 281-289(9)
Authors: Lagos-Jaramillo, Veronica; Press, Michael; Ricker, Charité; Dubeau, Louis; Mai, Phuong; Weitzel, Jeffrey

Breast cancer risk assessment in women aged 70 and older
pp. 291-299(9)
Authors: Vacek, Pamela; Skelly, Joan; Geller, Berta

A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men
pp. 301-306(6)
Authors: Reiner, Anne; Jacks, Lindsay; Zee, Kimberly; Panageas, Katherine

Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression
pp. 307-317(11)
Authors: Fu, Peifen; Ibusuki, Mutsuko; Yamamoto, Yutaka; Hayashi, Mitsuhiro; Murakami, Keiichi; Zheng, Shusen; Iwase, Hirotaka

Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer
pp. 319-329(11)
Authors: Huang, Katie; Takano, Elena; Mikeska, Thomas; Byrne, David; Dobrovic, Alexander; Fox, Stephen

Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer
pp. 331-339(9)
Authors: Yoshimoto, Nobuyasu; Toyama, Tatsuya; Takahashi, Satoru; Sugiura, Hiroshi; Endo, Yumi; Iwasa, Mai; Fujii, Yoshitaka; Yamashita, Hiroko

Identification of a new complex rearrangement affecting exon 20 of BRCA1
pp. 341-344(4)
Authors: Valle, Jesús; Campos, Olga; Velasco, Angela; Darder, Esther; Menéndez, Mireia; Feliubadaló, Lídia; Tornero, Eva; Blanco, Ignacio; Izquierdo, Ángel; Brunet, Joan; Capellá, Gabriel; Lázaro, Conxi

Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era
pp. 345-351(7)
Authors: Chen, I.; Lin, C.; Huang, C.; Lien, H.; Hsu, Chiun; Kuo, W.; Lu, Y.; Cheng, A.

Re Panoff et al., Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation
pp. 353-355(3)
Author: Graham, Peter

Polymorphisms of matrix metalloproteinases (MMP) gene and breast cancer risk: appraisal of a recent meta-analysis
pp. 357-358(2)
Authors: Wu, Xiao-Yang; Chen, Min-Bin; Wang, Li-Qiang; Xu, Yan; Tan, Yue; Shen, Wen-Xiang

Detection of circulating tumor cells by RT-PCR significantly associated with poor prognosis in breast cancer
pp. 359-364(6)
Authors: Zhang, Liling; Wu, Gang; Pantel, Klaus